Preclinical studies suggest that flavonoids possess antidepressant properties by reversing depression-related deficits through their antioxidant activity, neurotransmitter modulation, increased BDNF levels, and regulation of key enzyme activities (373). Here, BDNF is linked to major depressive disorder.